Bill Buese
Analyst · Truist. Your line is now live
Thank you, Tim, and good morning, everyone. As Tim suggested in his remarks, we had another solid quarter on both the operational and financial fronts, larger driven by the continued outperformance of our 2021 development program and supported by a strong commodity price environment. I'll now take a few minutes to provide a high level overview of our first quarter financial results and update on our improved liquidity position, spring redetermination process and return of capital initiatives before opening the call up for Q&A. For the three-month period ended March 31, 2022, we reported a net loss of $492 million and generated $235 million of adjusted EBITDA. A $664 million unrealized loss associated with our commodity derivative portfolio driven by the large increase in commodity prices during the quarter was the key driver of the net loss for the period. Net cash provided by operating activities totaled $254 million during the first quarter and we generated free cash flow of $117 million for the same period. We used the majority of our free cash flow to repay borrowings on our credit facility and to fund our ongoing common share repurchase program. On the derivative front, we entered into commodity derivative contracts during the first quarter to opportunistically hedge and lock in future free cash flow generation. As of May 2, we had natural gas swap and collar contracts totaling approximately 621 million cubic feet per day at an average floor price of $2.66 per Mcf for 2022 and natural gas swap and collar contracts totaling approximately 450 million cubic feet per day at an average floor price of $3.19 per Mcf for 2023. We also began layering in derivatives for 2024 and currently have natural gas swap contracts totaling approximately 35 million cubic feet per day at an average floor price of $3.77 per Mcf. Finally, we continue to restructure a portion of our 2023 sold call positions to provide additional capacity to layer in incremental swap and collar contracts. All of the contracts associated with the restructurings have been included in the derivative table in the 10-Q and were included in the updated numbers I shared earlier. Please see our Form 10-Q for additional details on our portfolio. Turning to our balance sheet. At the end of the first quarter, total assets were approximately $2.2 billion, while total gross debt was approximately $575 million consisting of $25 million outstanding under our revolver and $550 million of outstanding senior notes. We also had $6 million of cash on hand and $113 million of letters of credit outstanding at the end of the quarter. On the liquidity front, we exited the first quarter with approximately $568 million of total liquidity made up of $6 million of cash and $562 million available under the revolver. We recently completed our spring borrowing base redetermination process and effective May 2, we entered into the first amendment to the credit agreement, governing our credit facility. Our lenders approved an increase in our borrowing base from $850 million to $1 billion, while we chose to keep the elected lender commitments at $700 million. We believe the increased borrowing base reflects the strength of our assets, our improved balance sheet and the current commodity market. In addition, the Amendment eased certain requirements and limitations related to hedging, amended the covenants governing certain restricted payments and provides for the transition from a LIBOR to a SOFR benchmark. Overall, we think the redetermination and amendment were extremely positive outcomes for the company. On the return of capital front, as indicated during our fourth quarter earnings call, we began executing on our initial $100 million common share repurchase program during the quarter. As of March 31, we have repurchased approximately 438,000 common shares at an average price of $80.16 for a total cost of $35.5 million. Subsequent to the end of the quarter, we continued to repurchase shares. And as of May 2, we had repurchased approximately 748,000 common shares in total at an average price of $84.26 for a total cost of $63 million. This left approximately $37 million under our original common share repurchase authorization. As Tim just mentioned in his comments, the Board authorized an additional $100 million to be added to our common share repurchase program. The increase provides for a total of $200 million of our common shares to be repurchased through December 31st of this year. The increased repurchase program represents approximately 50% of our free cash flow generation in 2022. And when combined with the shares already repurchased, approximately 10% of our outstanding common shares have executed at today's share price. As well as the case with the initial authorization, the timing and amount of any share repurchases continues to be subject to available liquidity, market conditions, applicable or legal requirements, and other factors. We will continue to evaluate all of our future return of capital options, including continuing to increase the size of our share repurchase program, potentially addressing the preferred shares and instituting a common share dividend. In summary, we continued to generate significant free cash flow, which has allowed us to pay down the majority of our credit facility and to begin executing on our stock repurchase program. Our outlook for free cash flow continues to improve despite the growing inflationary effects that has led to an increased capital spend for 2022. We continue to believe that our efficient asset base supports a low reinvestment rate that will allow us to continue returning capital to shareholders while maintaining a strong production portfolio, financial position and leverage below one-time. With that, we will now open the call up for questions.